
GENE THERAPY FOR PARKINSON'S
More than one and a half million Americans suffer from Parkinson's disease. There is no cure. But now there is a new treatment that may improve patients' quality of life.
 |
Transcript of the story
|
 |
Healthy For Life Extra extra information about the story |
 |
For More Information where to go for help |
At 58, Jean Erickson began noticing signs that something was very wrong.
Jean Erickson
Has Parkinson's
"I would freeze. I would start to walk and then suddenly I couldn't walk anymore."
Jean has Parkinson's disease -- a neurologic condition that causes tremors. Like many patients, her medications stopped working properly, so she volunteered for a clinical trial on gene therapy.
Chad Christine, MD
"The upper dots represented the tracks of the needles."
With the new therapy, doctors insert needles in the head to infuse a virus that releases a gene deep in the brain.
Chad Christine, MD
Neurologist
University of California, San Francisco
San Francisco, CA
"Our gene therapy is one that is directed at replacing an enzyme that is lost as Parkinson's disease progresses."
Jean is one of four people who's tried the therapy. So far, all the patients reported improvements and have not had to increase their meds.
Chad Christine, MD
"We are delighted to observe that patients seem to be getting improvement from this low dose and are hopeful that even higher doses will be more effective."
Jean hopes so, too.
Jean Erickson
"I can walk better. I can talk better. My speech, eating in restaurants, isn't as draining as it used to be."
It took courage to be one of the first to try a new treatment. Jean says she's glad she did.
As the clinical trial continues, patients will receive higher doses of the gene therapy. Doctors hope to see even more striking results. Right now, it looks like the therapy will be a one-time treatment.
BACKGROUND: Parkinson's disease is a movement disorder that is chronic and progressive, meaning symptoms continue and worsen over time. More than 1 million Americans suffer from Parkinson's disease. While about 15 percent of people with Parkinson's are diagnosed before the age of 40, incidence increases with age. Parkinson's disease occurs when a group of cells in an area of the brain called the substantia nigra begin to malfunction and die. These cells in the substantia nigra produce a chemical called dopamine. Dopamine is a neurotransmitter, or chemical messenger, that sends information to the parts of the brain that control movement and coordination. When a person has Parkinson's disease, their dopamine-producing cells begin to die, and the amount of dopamine produced in the brain decreases. Messages from the brain telling the body how and when to move are, therefore, delivered more slowly, leaving a person incapable of initiating and controlling movements in a normal way. Parkinson's disease can cause several different symptoms. Some of the most common symptoms include:
tremor of the hands, arms, legs, jaw and face
stiffness of the limbs and trunk
slowness of movement
impaired balance and coordination
CURRENT TREATMENTS: There are many therapies available used to treat the symptoms of Parkinson's. One of the most common is a medication called Levodopa. Levodopa is a substance that is converted into dopamine by an enzyme in the brain. It is then released by brain cells and activates dopamine receptors, allowing for normal function of the movement control centers of the brain. Between 70 percent and 80 percent of treated Parkinson's patients take levodopa therapy. It is considered the "gold standard" treatment. One problem with the current medication is that it can eventually "wear off" and become less effective at controlling symptoms.
A NEW APPROACH: Researchers are now studying gene therapy for patients with Parkinson's disease. There are a couple different clinical trials testing this method. One trial, conducted by researchers from the University of California, San Francisco, is testing whether replacing an enzyme that as lost as Parkinson's disease progresses can help patients. For the study, doctors insert needles in the head to infuse a harmless virus that releases a gene deep into the brain. Chad Christine, M.D., a neurologist at UCSF, says: "We use a virus that's able to carry the gene deep into brain cells that are living and are healthy in the region where dopamine is normally released." Researchers have tested the therapy on four patients to date. So far, the results have been encouraging. "Patients seem to notice that their medications are lasting a bit longer and that they're moving a little more easily. We've not had to increase the medications for any of the patients, and that's very encouraging in a disease that is normally progressing and requires more and more medication as time goes on," says Dr. Christine. "Our hope is to reverse the disease a little bit, not by slowing down the condition itself, but by improving the response to the medications."
Carol Hyman
University of California, San Francisco
3333 California St.
St. 103
San Francisco, CA 94143-0462
chyman@pubaff.ucsf.edu
http://pub.ucsf.edu/newsservices/
Copyright © 2006 Ivanhoe Broadcast News, Inc.
|
 |
 |
 |


REVERSING SCLERODERMA
A risky treatment could be the answer for patients with serious forms of this disease. 
COLONOSCOPY-NOT JUST FOR COLON CANCER
A virtual colonoscopy detects a wide range of diseases outside the colon, which could save lives. June is national Scleroderma Awareness Month! 
CLEARER MRI
A new invention helps doctors get clearer images of people who can't lie still. 
HELP FOR BLOOD PRESSURE
An investigational device could help patients with this condition stay healthier. 
SEEING THE HEART IN 3D
Researchers in the Netherlands are using virtual reality to see the heart like never before. 
PANCREATIC CANCER VACCINE
A vaccine increases survival for patients with this deadly form of cancer. 
NEW HELP FOR ALCOHOLICS
People who suffer from addiction may have a new option in the form of a pill. 
TREATING URINARY INCONTINENCE
A sling helps women with this common problem find relief. 
ROBOT REHAB FOR STROKE
A new robot is helping stroke patients recover without a therapist. 
STEM CELLS HEAL HEARTS
Donor stem cells may be the answer for patients who suffer a heart attack. 
BREATHING WITH EMPHYSEMA
A new, nonsurgical procedure could help patients breathe more easily. 
DOPPLER PREDICTS STROKE
The same technology used to forecast a storm is helping doctors understand strokes and migraines. 
BETTER BYPASS SURGERY
Cutting-edge technology allows doctors to fix a coronary bypass operation while the patient is still in surgery. 
BETTER KIDNEY TRANSPLANT TREATMENT
A new treatment could reduce the risk of rejection within six months of a transplant. 
WRAPPING RADIATION AROUND TUMORS
New technology allows doctors to target tumors with better precision. 
CUTTING-EDGE SURGERY EDUCATION
Huge monitors and microscopic cameras are making it easier for surgeons to teach residents complicated procedures. 
LUNG CANCER VACCINE
A vaccine under study offers hope for some patients who are diagnosed with this deadly cancer. 
EASIER COLON CANCER TEST
A blood test may be the future in screening for colon cancer. 
STEM CELLS FIGHT LUPUS
Using a patient's own stem cells could provide a cure for this devastating disease. 
NEW SINUS RELIEF WITH A BALLOON
A new technique pushes sinus blockages out of the way and results in less pain. 
HUNTINGTON'S HELP
A drug already approved in Europe and Canada could offer hope to patients who are plagued by this disease. 
INHALED CHEMO
A new twist on standard chemotherapy offers less side effects and better precision. 
STRENGTHENING BRITTLE BONES
A drug to treat osteoporosis is helping patients with a disease that weakens their bones. 
BIRD FLU: BE PREPARED
Find out what you can do to prepare for the flu that experts think will hit the states in the coming months. 
|